Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19.

Muralidharan, Nisha; Sakthivel, R; Velmurugan, D; Gromiha, M Michael

Muralidharan, Nisha; Sakthivel, R; Velmurugan, D; Gromiha, M Michael.

Afiliación

Muralidharan N; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
Sakthivel R; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
Velmurugan D; School of Bioengineering, Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Chennai, India.
Gromiha MM; Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.

J Biomol Struct Dyn ; 39(7): 2673-2678, 2021 04.

Article en En | MEDLINE | ID: mdl-32248766

Asunto(s)

Tratamiento Farmacológico de COVID-19; Ritonavir; Antivirales/farmacología; Antivirales/uso terapéutico; Combinación de Medicamentos; Reposicionamiento de Medicamentos; Humanos; Lopinavir; Oseltamivir; Péptido Hidrolasas; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ritonavir / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: J Biomol Struct Dyn Año: 2021 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google